NCT03043950Completed
Validation of a New Prognostic Score for Adult Patients With RAS Wild-type mCRC Treated With Vectibix® and FOLFIRI or FOLFOX in First Line (VALIDATE)
A Non-interventional Study to Assess the Safety and Efficacy of First Line Therapy With Vectibix® in Combination With FOLFIRI or FOLFOX and to Validate a Prognostic Score in Adult Patients With RAS Wild-type Metastatic Colorectal Cancer in a Real World Setting (VALIDATE)
Source: ClinicalTrials.gov · Last updated 24 Apr 2024
Brief summary (registry, in English)
A safety and efficacy study of first line therapy with Vectibix® in combination with FOLFIRI or FOLFOX to validate a prognostic score in adult patients with RAS wild-type metastatic colorectal cancer in a real world setting (VALIDATE)
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 647 (actual)
- First submitted
- 2 Feb 2017
- Start date
- 25 Jan 2017
- Primary completion date
- 17 Jan 2024
- Lead sponsor
- iOMEDICO AG
- Diseases
- Colorectal cancer
- NCT number
- NCT03043950
What you commit to
- Study type: Observational
- Participants enrolled: 647
- From 25 Jan 2017 to the primary completion date, 17 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Any contraindication according to current SmPC
- Participation in other clinical trials
Who the study is looking for
- Eligibility according to current SmPC
- Signed written informed consent
- Diagnosis of RAS-WT mCRC
- No prior systemic therapy in the palliative setting
- Aged 18 years or older
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Praxis für interdisziplinäre Onkologie & Hämatologie Coordinator of this site? Confirm its status | Freiburg im Breisgau | Germany | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.